SUMMARY A longitudinal study has been set up to examine the incidence of ischaemic heart disease and its associations with serum lipoproteins including high density lipoprotein cholesterol and its subfractions, certain haemostatic factors, and other "risk" factors. We report here on our pilot study findings.
Cross-sectional data were available on 283 men and 68 women aged 45 to 64 representing 85% of the available population randomly selected from the lists of 16 general practitioners.
Reproducibility of the measurements of total serum cholesterol, triglyceride, and low density lipoprotein cholesterol was acceptable. The reproducibility of some of the other serum lipid fractions, for example high density lipoprotein cholesterol, was less good, in part because of the small range of the values found for these components.
Univariate associations of physical and behavioural characteristics and serum lipoproteins of men and women, with and without ischaemic heart disease, disclosed small and statistically nonsignificant differences except for levels of blood pressure. In particular, there was no significant difference in mean levels of serum high density lipoprotein cholesterol between men with ischaemic heart disease (091 mmol/1) and men without it (0.94 mmol/l).
In examining our data for the determinants of serum high density lipoprotein cholesterol using a linear multiple regression model, sex, serum high density lipoprotein cholesterol, and very low density lipoprotein triglyceride were the major factors, each individually explaining about 7% of the variance of serum high density lipoprotein cholesterol levels. In addition, alcohol intake and obesity each explained a further 2% of the variance.
The experience of the pilot study has led to modifications in the collection of blood samples and the subsequent estimation of lipid fractions.
In 1975, Miller and Miller' published their hypothesis in which they suggested that reduced levels of plasma high density lipoprotein might accelerate the development of atherosclerosis and, in turn, ischaemic heart disease. We considered that the evidence marshalled for that paper, together with new data, was sufficient to justify the establishment in Bristol of a longitudinal study whose main objective would be the examination of the association of plasma high density lipoprotein cholesterol levels and the development subsequently of ischaemic heart disease.
Accepted for publication 5 January 1982 In order to examine the feasibility of such a study, we have carried out a pilot study whose principal aims were to determine (a) the likely response rate, (b) the feasibility of collecting fasting samples of blood, and (c) the suitability of certain laboratory methods for the longitudinal study. We report here on the findings of the pilot study which includes only data on prevalent ischaemic heart disease. Since we began this study other workers have reported their findings on the association of plasma high density lipoprotein and incidence of ischaemic heart disease. In these centres high density lipoprotein data were already available,2 or were obtained from deep frozen samples which had been collected two years previously.3
Patients and methods
The patients on the lists of 16 general practitioners based at two health centres serving adjoining areas of mixed social class were identified by age and sex and a random sample of 400 men and 100 women aged between 45 to 64 years was drawn. The reasons for choosing this number was that in men we wished to examine the levels of plasma high density lipoprotein in those with and without ischaemic heart disease. The expected lower prevalence of ischaemic heart disease in women would have necessitated a larger number of women to obtain estimates with reasonable precision, and we did not attempt this.
For both sexes we wished to examine the relation of high density lipoprotein to variables (other than ischaemic heart disease) such as low density lipoprotein cholesterol, very low density lipoprotein triglycerides, and obesity-data which would be available for every subject.
Subjects were asked to attend a local clinic where a history was obtained by questionnaire to determine a present or past history of ischaemic heart disease,4 risk factors for this condition, and certain variables which are known to influence lipid metabolism. Subjects were measured for height, weight, and skinfold thickness, using standard anthropometric methods. were sent from the clinic, the laboratory workers were unaware of their identity. Plasma glucose was measured by the automated glucose oxidase method of Trinder.'I
The prevalence of ischaemic heart disease was estimated by three criteria: the presence of angina and a history of myocardial infarction using the standard WHO questionnaire for both,4 and by electrocardiographic abnormalities. All electrocardiograms were classified by one observer using the Minnesota code" I and subdivided into three groups: probable ischaemia (items 1-1, 1-2, 7-1); possible ischaemia (items 1-3, 4-1 to 4-3, 5-1 to 5-3); and no ischaemia (none of the above). 12 Because of the small number of cases of ischaemic heart disease in the study, the univariate association of ischaemic heart disease with the various measurements has been recorded in this paper with all categories of ischaemic heart disease combined (any Table 2 Table 3 . Reproducibility of the remaining lipoprotein fractions, though more difficult to interpret, appeared to be less acceptable. The minimal recordable difference between pairs of samples for cholesterol was 0.1 mmolIl, which was 10% of the overall mean for high density lipoprotein cholesterol. Of 44 pairs of samples for high density lipoprotein cholesterol estimation, 17 had, in fact, differences of 0-1 mmol/I or less. The prevalence of various categories of ischaemic heart disease is shown in Table 4 . The individual categories of ischaemic heart disease were not mutually exclusive but there is little overlap of categories, especially in the younger age group. The prevalence of ischaemic heart disease in women was slightly higher than in men but the number of female cases is extremely small and these rates lack precision. In the rest of the tables data referring to ischaemic heart disease in women have not been given for this reason.
Univariate associations of physical and behavioural characteristics of the men and women and the presence and absence of ischaemic heart disease disclosed small and statistically non-significant differences apart from levels of blood pressure. In men, systolic and diastolic blood pressure levels were higher in those with ischaemic heart disease compared with levels in those without ischaemic heart disease (mean systolic blood pressure with ischaemic heart disease 160 mmHg (SD 30), without ischaemic heart disease 144 mmHg (SD 25); mean diastolic blood pressure with ischaemic heart disease 89 mmHg (SD 15), without ischaemic heart disease 85 mmHg (SD 13)). Differences between mean systolic and mean diastolic blood pressure with and without ischaemic heart disease were statistically significant (p<0-001 and p<0-05, respectively). Differences in the same direction for systolic and diastolic blood pressure levels in women were observed.
The associations between ischaemic heart disease and total cholesterol, total triglyceride, the lipoprotein lipids, and plasma glucose are shown in Table 5 . The differences in concentrations of these lipids and lipoprotein fractions in men with and without ischaemic heart disease were small, and did not achieve statistical significance. Plasma glucose was higher in men with ischaemic heart disease ( Table 5 ), but the difference from levels in those without ischaemic heart disease did not achieve statistical significance. The association of ischaemic heart disease and high density lipoprotein cholesterol concentrations was analysed further for two male age groups by each category of ischaemic heart disease-angina, history of myocardial infarction, and possible and probable electrocardiographic evidence of ischaemic heart disease. Differences in the concentration of high density lipoprotein cholesterol within these ischaemic heart disease categories for all age groups with and without evidence of the disease were small, inconsistent, and did not achieve statistical significance (Table  6) .
Consideration of the eight variates singly as deter- (Table 7) . High density lipoprotein cholesterol levels rose with increasing alcohol intake in men and women (Table 8) . As the index of obesity (weight/height2) rose in men and women, high density lipoprotein cholesterol concentrations decreased ( Table 9 ). Concentrations of high density lipoprotein cholesterol fell as low density lipoprotein cholesterol *See footnote to Table 7 .
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The eight variates were included in a multiple regression model with, as the dependent variables in turn, the high density lipoprotein cholesterol and the log high density lipoprotein cholesterol concentrations. It was found that the assumptions of the model were better satisfied by choosing the log values of high density lipoprotein cholesterol as the dependent variable. The full model explained 31.90/o of the total variance of log high density lipoprotein cholesterol concentration. Sex, low density lipoprotein cholesterol, and very low density lipoprotein triglyceride were each significantly associated with high density lipoprotein cholesterol concentration (p<0.001). Each variate explained individually around 7% of the variance in high density lipoprotein cholesterol concentration. Alcohol and obesity index were also highly significantly associated with high density lipoprotein cholesterol concentration, with each variate explaining about 2% of the variance.
Age, smoking habit, and physical activity were not associated with high density lipoprotein cholesterol level using this model. A five variate model excluding these same three factors explained 31-7% of the total variance of log high density lipoprotein cholesterol concentrations.
Discussion
The feasibility of undertaking a longitudinal study of the associations between ischaemic heart disease and plasma lipids and lipoproteins was supported by the satisfactory response of those available within the population sample.
We were particularly encouraged by the willingness of our subjects to fast overnight and attend a clinic the following morning. We made this easier for our subjects by starting the clinic relatively early (7.15 am) and providing breakfast. In this way our subjects usually stopped off at the clinic on their way to work. Subjects who could not attend the clinic because they left for work before the clinic began were visited at home.
Reproducibilty of the lipid measurements was difficult to interpret because of the narrow range of values for some of the components. The coefficients of variation for high density lipoprotein cholesterol and very low density lipoprotein triglyceride were, however, sizeable, and were considered unacceptable for a longitudinal study. This has led to modifications in our methods, which include the use of Na2 EDTAplasma rather than serum, a reduction of the interval between venepuncture and lipoprotein quantification, the use of conventional preparative ultracentrifugation to isolate very low density lipoprotein, an increase in the final concentration of MnCl2 (to 0 09 M) used for the very low density lipoprotein/low density lipoprotein precipitation,'4 and the measurement of lipid concentrations enzymatically in a centrifugal analyser (Table 1) .
The prevalence of ischaemic heart disease in men was similar to that recorded by Reid and others in the Whitehall study using similar information from medical histories and electrocardiograms.'5 The overall prevalence (any ischaemic heart disease) for men in the Whitehall study was 11-3%, 17%, and 22*5% for men aged 40 to 49, 50 to 59, and 60 to 69 years, respectively.
The univariate associations of "risk" factors, including total cholesterol and triglyceride and the lipoproteins in particular, with ischaemic heart disease were not obvious except for blood pressure levels. Total cholesterol was marginally higher in those with ischaemic heart disease for both men and women. High density lipoprotein cholesterol was lower in men with ischaemic heart disease than in those without it. The ratio of high density lipoprotein/total cholesterol was marginally higher in men without ischaemic heart disease compared with men with it. The lack of clear association between these lipids and prevalent ischaemic heart disease is not unusual: for example the Framingham study showed no association between prevalence of ischaemic heart disease and total cholesterol. 16 Because of the inverse associations of high density lipoprotein cholesterol and incidence of ischaemic heart disease reported from Framingham,2 Tromso,3 and Israel, '7 
